• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success

    4/28/26 10:12:00 AM ET
    $CB
    Property-Casualty Insurers
    Finance
    Get the next $CB alert in real time by email

    BOCA RATON, Fla., April 28, 2026 /PRNewswire/ -- Verified Clinical Trials (VCT), the global leader in clinical trial subject registry solutions, and Chubb today announced a strategic alliance focused on enhancing research subject safety, improving data quality, strengthening study integrity, and supporting successful clinical trial outcomes.

    Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success.

    "Chubb is committed to supporting innovative and practical approaches to risk management in clinical research," said Lee Farrow, EVP, Life Sciences Industry Practice Leader at Chubb.

    Chubb's partnering with Verified Clinical Trials, who offers proprietary subject registry technology, is part of a broader clinical trial risk management approach. VCT's clinical trial subject registry solutions are designed to detect and help prevent duplicate enrollment and other important protocol violations at the time of screening - issues that can compromise research subject safety, affect data quality, create operational and regulatory challenges, and increase the risk of study failure.

    Key Benefits of the Alliance Include:

    • Enhanced Research Subject Safety: Helping reduce the risk of duplicate or overlapping study participation that may contribute to adverse events, drug interactions, and other safety concerns.
    • Improved Data Quality: Supporting cleaner, more reliable study data for stronger analysis, decision-making, and regulatory submissions.
    • Greater Study Integrity: Helping reinforce protocol compliance and protect against violations that can undermine trial validity.
    • Reduced Risk Exposure: Helping sponsors, CROs, and sites mitigate preventable operational, financial, regulatory, and potential liability risks.
    • Stronger Potential for Clinical Trial Success: Supporting better-protected studies with a higher likelihood of meeting research objectives.
    • Broader Public Benefit: Helping support the development of safer, more effective drugs and therapies for the patients and communities who rely on them.

    Chubb is the leading global underwriter of clinical trials and a longstanding market leader that tailors insurance solutions for life sciences companies, with the scale, expertise, and international capabilities to support pharmaceutical and biotechnology companies ranging from emerging innovators to some of the largest in the world. Chubb clients can benefit from an additional layer of protection against adverse events (AEs), serious adverse events (SAEs), protocol deviations, and compromised data quality associated with duplicate or undisclosed study participation.

    By combining Chubb's clinical trial insurance capabilities with VCT's industry-recognized subject registry technology, this alliance is positioned to provide meaningful, additive benefits to sponsors, CROs, research sites, and ultimately research subjects. Together, these complementary services can help reduce preventable risk, improve research subject safety, strengthen protocol compliance, enhance data quality and study integrity, and support more successful clinical trial execution.

    "Research subject safety and data integrity are fundamental to every successful clinical trial," said Dr. Mitchell Efros, Co-Founder & CEO at Verified Clinical Trials. "This alliance with Chubb represents an important opportunity to help bring greater protection, stronger oversight, and added value to the clinical research ecosystem. Ultimately, the broader public stands to benefit as well, as safer, more effective drugs and therapies can be developed and brought forward with greater confidence for patient use."

    "Chubb is committed to supporting innovative and practical approaches to risk management in clinical research," said Lee Farrow, EVP, Life Sciences Industry Practice Leader at Chubb. "VCT addresses a longstanding and underrecognized challenge in clinical research: the inability to reliably look into a participant's research history to confirm eligibility. This alliance with VCT reflects a shared focus on improving research subject safety, study integrity, and overall trial performance."

    "At Verified Clinical Trials, our mission has always been to strengthen the integrity of clinical research while prioritizing the safety of research participants," said Kerri Weingard, Co-Founder, VP and Global COO of Verified Clinical Trials. "This alliance with Chubb represents a meaningful advancement in how the industry approaches risk - moving from reactive to proactive safeguards. By combining VCT's real-time subject verification capabilities with Chubb's global risk management expertise, we are helping to create a more secure, transparent, and reliable clinical trial ecosystem that ultimately benefits sponsors, sites, and, most importantly, patients."

    This alliance represents an important step forward in advancing proactive risk management in clinical trials and underscores the value of collaboration between insurers and clinical trial technology leaders working to improve clinical research outcomes worldwide.

    About Verified Clinical Trials

    Verified Clinical Trials (VCT) is a leading provider of clinical trial subject registry solutions designed to detect and help prevent duplicate enrollment and other protocol violations. Its secure global database is trusted by research sites, sponsors, and CROs to help improve research subject safety, strengthen protocol compliance, and protect data integrity.

    About Chubb

    Chubb is a world leader in insurance. With operations in 54 countries and territories, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. The company is defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (NYSE:CB) and is a component of the S&P 500 index. Chubb employs approximately 45,000 people worldwide. Additional information can be found at: https://www.chubb.com/.

    Media Contact:

    Justin Goodarz

    Chief Commercial Officer

    Verified Clinical Trials, LLC

    Connect@verifiedclinicaltrials.com

    (516) 998-7499

    Disclaimer: The non-insurance products and services described herein are provided by Verified Clinical Trials, a third party vendor not affiliated with Chubb. The fact that offers and potential discounts may be made available by this vendor is not an indication that insurance coverage is available under any Chubb policy for any particular incident. Referenced discounts on products and services offered by Verified Clinical Trials are available only to Chubb policyholders with current in-force policies and are subject to applicable insurance laws. For products and services provided, the policyholder and third party vendor would enter into a vendor relationship directly. Chubb will not be involved in the policyholder's decision to purchase services and has no responsibility for services that may be provided. 

    Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/verified-clinical-trials-and-chubb-announce-strategic-alliance-to-advance-research-subject-safety-data-quality-and-clinical-trial-success-302755827.html

    SOURCE Verified Clinical Trials LLC

    Get the next $CB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CB

    DatePrice TargetRatingAnalyst
    1/8/2026$351.00Neutral → Buy
    Goldman
    12/16/2025$318.00Neutral
    Mizuho
    9/16/2025$320.00Outperform
    Wolfe Research
    8/13/2025$290.00Neutral
    Cantor Fitzgerald
    8/13/2025$326.00Buy
    Citigroup
    8/1/2025$300.00Buy → Hold
    HSBC Securities
    7/24/2025$283.00Overweight → Neutral
    Piper Sandler
    7/7/2025$298.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $CB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chubb Limited Shareholders Approve 33rd Consecutive Annual Dividend Increase; Chubb Limited Board Declares Record Date for First Dividend Installment and Authorizes New Share Repurchase Program

    ZURICH, May 21, 2026 /PRNewswire/ -- Chubb Limited (NYSE:CB) announced today that at its 2026 Annual General Meeting, held at the company's offices in Zurich, Switzerland, shareholders approved a 5.2% increase in the company's dividend to $4.08 per share annually ($1.02 per share, per quarter) from $3.88 per share ($0.97 per share, per quarter). This marks the 33rd consecutive annual increase in the company's dividend. Shareholders also voted in line with the Board's recommendations on all other agenda items at the Annual General Meeting. The dividend will be payable out of lega

    5/21/26 10:00:00 AM ET
    $CB
    Property-Casualty Insurers
    Finance

    Chubb Limited Announces Pricing of $1 Billion Senior Notes Offering by Subsidiary

    ZURICH, May 18, 2026 /PRNewswire/ -- Chubb Limited (NYSE:CB) announced today that its subsidiary, Chubb INA Holdings LLC, has priced a public offering of $1 billion of 5.30% senior notes due 2036 (the "2036 Notes"). The 2036 Notes are guaranteed by Chubb Limited.  Chubb intends to use the net proceeds for general corporate purposes, which may include the repayment or refinancing of debt. The joint book-running managers for the offering are Barclays Capital Inc. and Wells Fargo Securities, LLC.This press release is for informational purposes only and does not constitute an offer

    5/18/26 6:47:00 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    Combined Canada Introduces New Cancer Care Insurance Product to Help Canadians Manage the Financial Impact of Cancer

    New offering provides flexible, cost-effective coverage designed to address rising out-of-pocket costs and deliver peace of mindMARKHAM, ON, May 13, 2026 /CNW/ -- Combined Canada, a Chubb Benefits Company and leading provider of supplemental accident, health, disability, and life insurance products in Canada, today announced the launch of Combined Cancer Care, a new insurance product designed to help Canadians navigate the financial challenges associated with a cancer diagnosis. According to the Canadian Medical Association Journal (CMAJ) and reported by the Canadian Cancer Soci

    5/13/26 2:00:00 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    $CB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chubb upgraded by Goldman with a new price target

    Goldman upgraded Chubb from Neutral to Buy and set a new price target of $351.00

    1/8/26 8:09:22 AM ET
    $CB
    Property-Casualty Insurers
    Finance

    Mizuho initiated coverage on Chubb with a new price target

    Mizuho initiated coverage of Chubb with a rating of Neutral and set a new price target of $318.00

    12/16/25 8:47:55 AM ET
    $CB
    Property-Casualty Insurers
    Finance

    Wolfe Research initiated coverage on Chubb with a new price target

    Wolfe Research initiated coverage of Chubb with a rating of Outperform and set a new price target of $320.00

    9/16/25 8:05:52 AM ET
    $CB
    Property-Casualty Insurers
    Finance

    $CB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President &COO Keogh John W sold $7,394,740 worth of shares (23,000 units at $321.51), gifted 62,352 shares and received a gift of 61,000 shares, decreasing direct ownership by 38% to 140,970 units (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    5/29/26 4:10:04 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    Director Hu Fred was granted 1,135 shares and covered exercise/tax liability with 193 shares, increasing direct ownership by 122% to 1,713 units (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    5/26/26 4:20:03 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    President &COO Keogh John W returned 5,033 shares to the company and covered exercise/tax liability with 29,556 shares, decreasing direct ownership by 13% to 226,322 units (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    5/26/26 4:20:04 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    $CB
    SEC Filings

    View All

    SEC Form 144 filed by Chubb Limited

    144 - Chubb Ltd (0000896159) (Subject)

    6/8/26 2:00:53 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    SEC Form S-8 filed by Chubb Limited

    S-8 - Chubb Ltd (0000896159) (Filer)

    5/27/26 4:07:07 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    Chubb Limited filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Chubb Ltd (0000896159) (Filer)

    5/22/26 4:09:45 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    $CB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Corbat Michael bought $114,665 worth of shares (425 units at $269.80), increasing direct ownership by 21% to 2,450 units (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    7/28/25 3:59:55 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    President & COO Keogh John W bought $2,874,135 worth of shares (9,810 units at $292.99) and sold $2,869,447 worth of shares (9,794 units at $292.99), increasing direct ownership by 4% to 247,538 units (SEC Form 4)

    4 - Chubb Ltd (0000896159) (Issuer)

    6/10/25 6:31:10 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    $CB
    Leadership Updates

    Live Leadership Updates

    View All

    Chubb Appoints Scott Henck Global Chief Actuary

    Cynthia Bentley promoted to succeed Henck as North America Chief Actuary; Paul O'Connell to RetireZURICH, Feb. 19, 2026 /PRNewswire/ -- Chubb Limited (NYSE:CB) today announced that Scott Henck, Executive Vice President and Chief Actuary, North America, has been appointed Senior Vice President, Chubb Group and Chief Actuary. He succeeds Paul O'Connell, who is retiring after a 40-year career in the property and casualty insurance industry. The appointment is effective April 1. In his new role, Henck will oversee all actuarial functions, including reserving, pricing and capital per

    2/19/26 1:36:00 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    Chubb Appoints Bill Hazelton Chief Operating Officer, North America Field Operations

    NEW YORK, Nov. 18, 2025 /PRNewswire/ -- Chubb today announced that Bill Hazelton has been appointed to Chief Operating Officer for North America Field Operations, effective December 1, 2025.  In this role, Bill will oversee the delivery of Chubb's full portfolio of personal and commercial insurance products and services to agent and broker distribution partners through 48 branch offices across North America.  He will also assist in the day-to-day management of North America Field Operations, with a specific focus on deepening Chubb's longstanding relationships with top trading

    11/18/25 8:30:00 AM ET
    $CB
    Property-Casualty Insurers
    Finance

    Chubb Appoints Susan Spivak to Lead Investor Relations

    ZURICH, Nov. 10, 2025 /PRNewswire/ -- Chubb Limited (NYSE:CB) today announced that Susan Spivak has been appointed to Senior Vice President of Investor Relations, effective November 17, 2025. Ms. Spivak brings more than two decades of experience in senior investor relations and equity markets roles. She previously led investor relations at The Hartford, Argo Group International Holdings and Alterra Capital Holdings (formerly Max Capital). Earlier in her career, she served as an equity analyst with Wachovia Securities, ABN Amro, and Donaldson, Lufkin & Jenrette. "We are pleased

    11/10/25 5:02:00 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    $CB
    Financials

    Live finance-specific insights

    View All

    Chubb Limited Shareholders Approve 33rd Consecutive Annual Dividend Increase; Chubb Limited Board Declares Record Date for First Dividend Installment and Authorizes New Share Repurchase Program

    ZURICH, May 21, 2026 /PRNewswire/ -- Chubb Limited (NYSE:CB) announced today that at its 2026 Annual General Meeting, held at the company's offices in Zurich, Switzerland, shareholders approved a 5.2% increase in the company's dividend to $4.08 per share annually ($1.02 per share, per quarter) from $3.88 per share ($0.97 per share, per quarter). This marks the 33rd consecutive annual increase in the company's dividend. Shareholders also voted in line with the Board's recommendations on all other agenda items at the Annual General Meeting. The dividend will be payable out of lega

    5/21/26 10:00:00 AM ET
    $CB
    Property-Casualty Insurers
    Finance

    Chubb Reports First Quarter Per Share Net Income and Core Operating Income of $5.88 and $6.82, Respectively, Up 78.8% and 85.2%; Consolidated Net Premiums Written of $14.0 Billion, Up 10.7%, with P&C and Life Insurance Up 7.2% and 33.1%; P&C Combined Ratio of 84.0%

    Net income and core operating income were $2.32 billion and $2.69 billion, respectively, up 74.3% and 80.6%.P&C net premiums written were $11.72 billion, up 7.2%, with consumer insurance up 14.2% and commercial insurance up 4.6%.North America was up 4.1%, including growth of 8.3% in personal insurance and 2.8% in commercial insurance, or 7.7% excluding large account property, both admitted and E&S.Overseas General was up 14.4%, including growth of 20.5% in consumer insurance and 10.8% in commercial insurance; Latin America, Europe and Asia were up 17.8%, 15.8% and 12.1%, respectively. On a constant dollars basis, Overseas General was up 6.1%, with consumer insurance up 11.1% and commercial i

    4/21/26 4:05:00 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    Chubb Limited to Hold its First Quarter Earnings Conference Call on Wednesday, April 22, 2026

    ZURICH, March 31, 2026 /PRNewswire/ -- Chubb Limited (NYSE:CB) will hold its first quarter earnings conference call on Wednesday, April 22, 2026, at 8:30 a.m. Eastern. The company expects to issue its first quarter earnings release and financial supplement after the market closes on Tuesday, April 21, 2026. These documents will be available on the company's investor website at investors.chubb.com.The earnings conference call will be available via live webcast at investors.chubb.com or by dialing 877-400-4403 (within the United States) or 332-251-2601 (international), passcode 16

    3/31/26 11:00:00 AM ET
    $CB
    Property-Casualty Insurers
    Finance

    $CB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Chubb Limited

    SC 13G/A - Chubb Ltd (0000896159) (Subject)

    11/14/24 1:22:34 PM ET
    $CB
    Property-Casualty Insurers
    Finance

    SEC Form SC 13G/A filed by Chubb Limited (Amendment)

    SC 13G/A - Chubb Ltd (0000896159) (Subject)

    2/14/24 10:02:59 AM ET
    $CB
    Property-Casualty Insurers
    Finance

    SEC Form SC 13G/A filed by Chubb Limited (Amendment)

    SC 13G/A - Chubb Ltd (0000896159) (Subject)

    2/14/23 12:38:03 PM ET
    $CB
    Property-Casualty Insurers
    Finance